"ARcare Center for Clinical Research is an independent research provider that conducts clinical research trials in digestive diseases including nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and colorectal cancer screening. Partnered with ObjectiveHealth and ARcare, our research center proudly offers the best possible care to you and your family in Conway, Arkansas. Our expertly trained medical staff seamlessly guides our patients through the clinical research process and provides every resource available. While gaining access to new research treatment options, our patients also have access to free diagnostics, FibroScan® testing, resources, and cost-effective additional care options."

During the past decade, Arcare Center for Clinical Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arcare Center for Clinical Research" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Arcare Center for Clinical Research" are "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "NASH" (1 trials) and "Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Arcare Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Arcare Center for Clinical Research" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "IVA337" (2 trials), "CSG452" (1 trials), "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arcare Center for Clinical Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Arcare Center for Clinical Research". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Arcare Center for Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arcare Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".